Replication Data for: Understanding the barriers and facilitators of human papillomavirus vaccine uptake in Kwale and Mombasa counties in Kenya; A study protocol

Human papillomavirus (HPV) vaccine has been available since 2006 for adolescent girls and women in an increasing number of countries globally. Evidence suggests that the vaccine is safe, highly effective and essential for protecting against the virus that is responsible for causing cervical cancer, a leading killer disease in women. Our study seeks to understand the social, behavioural and programmatic factors contributing to HPV vaccine uptake in the two counties of Kwale and Mombasa. Specifically, we are seeking to answer four questions: 1) What are the communities’ perceptions, feelings and thoughts about HPV vaccines? And how do these factors influence vaccine uptake; 2) What social processes drive HPV vaccination; 3) What factors lead to motivation to seek HPV vaccination?; and 4) How do HPV vaccine/vaccination-specific practical issues influence uptake? We anticipate that our study will contribute to the evidence that will help policymakers devise innovative ways to improve HPV vaccine coverage.